4//SEC Filing
LOVENBERG WALTER M PHD 4
Accession 0001209191-05-006605
CIK 0000729922other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 3:27 PM ET
Size
14.3 KB
Accession
0001209191-05-006605
Insider Transaction Report
Form 4
LOVENBERG WALTER M PHD
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2005-02-01−1,667→ 11,665 totalExercise: $9.25From: 1997-03-25Exp: 2006-03-24→ Common Stock (1,667 underlying) - Sale
Common Stock
2005-02-01$65.00/sh−223$14,495→ 9,496 total - Exercise/Conversion
Common Stock
2005-02-01$9.25/sh+1,667$15,420→ 9,719 total - Sale
Common Stock
2005-02-01$65.10/sh−447$29,100→ 9,049 total - Sale
Common Stock
2005-02-01$65.16/sh−774$50,434→ 8,052 total
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]One third of the stock option became exercisable one year after the date of the grant and the remainder vested ratably on a monthly basis over the succeeding 24 months.
- [F3]The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3.
- [F4]Includes only options with the same termination date.
Documents
Issuer
OSI PHARMACEUTICALS INC
CIK 0000729922
Entity typeother
Related Parties
1- filerCIK 0001213100
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 3:27 PM ET
- Size
- 14.3 KB